Why Did ARTL Stock Skyrocket Over 141% Pre-Market Today?

Artelo requested withdrawal of its Form S-1, effective March 25, and will not proceed with the planned securities offering.
In this photo illustration, an Artelo Biosciences logo is seen displayed on a smartphone screen.
In this photo illustration, an Artelo Biosciences logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
Profile Image
Shivani Kumaresan·Stocktwits
Published Mar 27, 2026   |   8:58 AM EDT
Share
·
Add us onAdd us on Google

Artelo Biosciences, Inc. (ARTL)  has formally requested the withdrawal of its recently effective registration statement for a planned securities offering, signaling a pause in its capital-raising efforts.

On Friday, the company submitted a request under Rule 477 of the Securities Act of 1933 to withdraw its Form S-1, initially filed with the U.S. Securities and Exchange Commission on March 20 and declared effective on March 25.

Artelo stated that it does not plan to move forward with the proposed securities offering at this time. Following the update, Artelo Biosciences stock traded over 141% higher in Friday’s premarket. 

Get updates to this developing story directly on Stocktwits.

Follow on Google News
Read about our editorial guidelines and ethics policy